LAUSR

Targeting BAP1: a new paradigm for mesothelioma.

Sign Up to like & get
recommendations!
0 Published in 2017 at "Lung cancer"

DOI: 10.1016/j.lungcan.2017.03.005

Abstract: New treatment strategies for malignant pleural mesothelioma (MPM) are important. BAP1 mutations are present in 47-67% of the MPM tumors, making this a good target for treatment. Multiple functions of BAP1 are investigated in the… read more here.

Keywords: mesothelioma; targeting bap1; bap1 new; new paradigm ... See more keywords